With MoCRA coming into force at the end of this year, the FDA has proposed that the Office of the Chief Scientist assume primary responsibility for color certification and cosmetic regulation oversight and enforcement.
Dr. Robert Califf now leads the US Department of Health and Human Services’ Food and Drug Administration. The cardiologist-by-training is expected to focus much more on issues of food, drug, and tobacco regulation than on cosmetics.
The Food and Drug Administration (FDA) has extended the comment period on guidance which could require cosmetics research to secure an Investigational New Drug (IND) before carrying out clinical trials.
The Food and Drug Administration has recently issued a warning in regards to ink/ pigments in tattoos having the potential to become contaminated by bacteria, mold, and fungus, if not handled in a sterilized environment. In this instance, Cosmetics Design...
The US Food and Drug Administration has released draft guidelines on the safety of nanomaterials in cosmetic products, urging manufacturers to meet with it before incorporating the ingredients into formulations, to substantiate the product’s safety.
The Food and Drug Administration has announced it will hold a public meeting to discuss the international cooperation on cosmetic regulations before its upcoming committee meeting in Rockville, Maryland in July.
Johnson & Johnson, L’Oreal and Avon were among many companies who showed up in support of cosmetic microbiological safety issues at the public meeting held by the Office of Cosmetic and Colors in Washington, D.C. last week
The US Food and Drug administration (FDA) is seeking permission
from the Chinese government to install eight full time FDA
officials in the country, as part of plans to improve monitoring of
exported food manufacturing across the...
A US-based medical organization has advised caution over the use of
cosmeceutical products, outlining the fact that they are largely
regulated as cosmetic products and not medicines, despite the
powerful active ingredients included...
A former FDA deputy commissioner for policy has denounced the
agency's capacity to properly regulate nanotechnology products
including supplements, a criticism that could inflame debate
leading up to the agency's first major...